about
Mining kidney toxicogenomic data by using gene co-expression modulesIntegrin-mediated type II TGF-β receptor tyrosine dephosphorylation controls SMAD-dependent profibrotic signaling.Effects of high glucose on integrin activity and fibronectin matrix assembly by mesangial cellsInactivation of integrin-β1 prevents the development of polycystic kidney disease after the loss of polycystin-1.p47(phox) contributes to albuminuria and kidney fibrosis in mice.Integrin Ligation Results in Nephrin Tyrosine Phosphorylation In Vitro.A Podocyte-Based Automated Screening Assay Identifies Protective Small Molecules.Urinary neutrophil gelatinase-associated lipocalin is associated with heavy metal exposure in welding workers.Implications of the differing roles of the β1 and β3 transmembrane and cytoplasmic domains for integrin function.MicroRNA regulation of integrins.One hundred ways to kill a podocyte.Deletion of β-1 integrin in collecting duct principal cells leads to tubular injury and renal medullary fibrosis.Notch: A multi-functional integrating system of microenvironmental signals.Podocyte-actin dynamics in health and disease.Rethinking glomerular basement membrane thickening in diabetic nephropathy: adaptive or pathogenic?Integrin alpha6 maintains the structural integrity of the kidney collecting system.Full-length soluble urokinase plasminogen activator receptor down-modulates nephrin expression in podocytes.An integrin antagonist (MK-0429) decreases proteinuria and renal fibrosis in the ZSF1 rat diabetic nephropathy model.Genetic and pharmacological inhibition of microRNA-92a maintains podocyte cell cycle quiescence and limits crescentic glomerulonephritis.Experimental Inhibition of Periostin Attenuates Kidney Fibrosis.Talin regulates integrin β1-dependent and -independent cell functions in ureteric bud development.Prospects for Precision Medicine in Glomerulonephritis Treatment.Update on Genetic Conditions Affecting the Skin and the Kidneys.Regulation of cofilin phosphorylation in glomerular podocytes by testis specific kinase 1 (TESK1)
P2860
Q28822270-80C5D938-0011-4959-90DB-DD3F03A449B3Q33944185-D7DD6A9E-4D21-4EC4-935D-B0BA263BDBB4Q34081401-21741248-4CE4-4A4C-AABB-77D65A40CE70Q35228509-64A324E7-465C-48C7-9FA0-41C3D62E87C9Q35587361-B2483956-4B7B-449B-B71E-26BFC5DF8879Q35915588-B0DD6D17-1FDC-4F76-90C7-4D2977417234Q36223325-612838A5-25B1-4CA5-9390-4715DD94CD00Q36379624-BC0DBBF1-EC5E-4E9F-B80E-0B9F37571D3DQ37552583-9E72CE06-A388-4D4E-9B0C-B0C1066893E2Q38314079-4B3CFD6B-34B7-49F6-B709-B566812E69D6Q38338547-05CD2063-A731-4F44-9B86-4851ADCD965BQ38682109-A92F48FB-26B8-47C1-8DAC-70EE6C36D907Q38937915-CB11FE52-6B5B-4006-B666-83BC976CF45FQ38940494-7ED67AA5-1E73-4BC4-B6DD-782020D9E071Q38942962-2549F111-8882-4C02-B213-1B385E916817Q39043889-33289A94-B615-4883-9446-A73689A911FFQ40528582-8B135488-DD53-4F17-89DD-59C4B6C749FCQ42285693-4F022BCB-42D9-4E16-91ED-1F079A7124F3Q47140728-CC5B54B0-6535-4081-A4FF-F6A739849B79Q47264485-1ECAB12D-0A76-427F-A513-1BCBD7D8C615Q47674930-8E1BEFEF-11C5-44FF-A200-9969BE293F40Q49300308-41C2FC9F-998A-4741-8AB1-91D6056DEFF9Q55140325-7BAC3353-304E-458C-8F90-9DE1C319518BQ58774752-C72AA080-A0C5-45F8-B245-AA37DA6AEEF0
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Integrins in kidney disease
@ast
Integrins in kidney disease
@en
Integrins in kidney disease
@nl
type
label
Integrins in kidney disease
@ast
Integrins in kidney disease
@en
Integrins in kidney disease
@nl
prefLabel
Integrins in kidney disease
@ast
Integrins in kidney disease
@en
Integrins in kidney disease
@nl
P2860
P3181
P356
P1476
Integrins in kidney disease
@en
P2093
P2860
P304
P3181
P356
10.1681/ASN.2013010012
P407
P577
2013-06-01T00:00:00Z